| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |